SYNDROS (Insys Therapeutics, Inc.)
Welcome to the PulseAid listing for the SYNDROS drug offered from Insys Therapeutics, Inc.. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Insys Therapeutics, Inc. |
| NON-PROPRIETARY NAME: | Dronabinol |
| SUBSTANCE NAME: | DRONABINOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-07-27 |
| END MARKETING DATE: | 0000-00-00 |
SYNDROS HUMAN PRESCRIPTION DRUG Details:
| Item Description | SYNDROS from Insys Therapeutics, Inc. |
| LABELER NAME: | Insys Therapeutics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2017-07-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 20482-335_40ab1c64-b842-4a71-baf4-eab1b5e365eb |
| PRODUCT NDC: | 20482-335 |
| APPLICATION NUMBER: | NDA205525 |
Other DRONABINOL Pharmaceutical Manufacturers / Labelers:
